Background: The Task Force on Promotion and Dissemination of Psychological Procedures proposed rigorous criteria to define empirically supported psychotherapies. According to these criteria, 2 randomized controlled trials (RCTs) showing efficacy are required for a treatment to be designated as ‘efficacious' and 1 RCT for a designation as ‘possibly efficacious'. Applying these criteria modified by Chambless and Hollon, this article presents an update on the evidence for psychodynamic therapy (PDT) in specific mental disorders. Methods: A systematic search was performed using the criteria by Chambless and Hollon for study selection, as follows: (1) RCT of PDT in adults, (2) use of reliable and valid measures for diagnosis and outcome, (3) use of treatment manuals or manual-like guidelines, (4) adult population treated for specific problems and (5) PDT superior to no treatment, placebo or alternative treatment or equivalent to an established treatment. Results: A total of 39 RCTs were included. Following Chambless and Hollon, PDT can presently be designated as efficacious in major depressive disorder (MDD), social anxiety disorder, borderline and heterogeneous personality disorders, somatoform pain disorder, and anorexia nervosa. For MDD, this also applies to the combination with pharmacotherapy. PDT can be considered as possibly efficacious in dysthymia, complicated grief, panic disorder, generalized anxiety disorder, and substance abuse/dependence. Evidence is lacking for obsessive-compulsive, posttraumatic stress, bipolar and schizophrenia spectrum disorder(s). Conclusions: Evidence has emerged that PDT is efficacious or possibly efficacious in a wide range of common mental disorders. Further research is required for those disorders for which sufficient evidence does not yet exist.

Keywords:
Psychodynamic psychotherapy, Empirically supported treatments, Psychotherapy outcome research, Evidence-based medicine
1.
Kessler RC, Berglund P, Demler O, Jin R, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62:593-602.
2.
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62:617-627.
3.
Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU: Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012;21:169-184.
4.
Norcross JC, Rogan JD: Psychologists conducting psychotherapy in 2012: current practices and historical trends among Division 29 members. Psychotherapy (Chic) 2013;50:490-495.
5.
Cook JM, Biyanova T, Elhai J, Schnurr PP, Coyne JC: What do psychotherapists really do in practice? An internet study of over 2,000 practitioners. Psychotherapy 2010;47:260-267.
6.
Chambless DL: Task Force on Promotion and Dissemination of Psychological Procedures: A Report Adopted by the Division 12 Board of the American Psychological Association. Oklahoma City, APA, 1993.
7.
Connolly Gibbons MB, Crits-Christoph P, Hearon B: The empirical status of psychodynamic therapies. Annu Rev Clin Psychol 2008;4:93-108.
8.
Chambless DL, Hollon SD: Defining empirically supported therapies. J Consult Clin Psychol 1998;66:7-18.
9.
Fonagy P, Roth A, Higgitt A: Psychodynamic therapies, evidence-based practice and clinical wisdom. Bull Menninger Clin 2005;69:1-58.
10.
Shedler J: The efficacy of psychodynamic psychotherapy. Am Psychol 2010;65 98-109.
11.
Gerber AJ, Kocsis JH, Milrod BL, Roose SP, Barber JP, Thase ME, Perkins P, Leon AC: A quality-based review of randomized controlled trials of psychodynamic psychotherapy. Am J Psychiatry 2011;168:19-28.
12.
Leichsenring F, Klein S: Evidence for psychodynamic psychotherapy in specific mental disorders: a systematic review. Psychoanal Psychother 2014;28:4-32.
13.
Abbass AA, Kisley SR, Town JM, Leichsenring F, Driessen E, De Maaat S, Gerber A, Dekker J, Rabung S, Rusalovska S, Crowe E: Short-term psychodynamic psychotherapy for common mental disorders. Cochrane database Syst Rev 2014;7:CD004687.
14.
Canadian Task Force on the Periodic Health Examination: The periodic health examination. Can Med Assoc J 1979;121:1193-1254.
15.
Clarke M, Oxman AD: Cochrane Reviewers' Handbook 4.1.6 (updated January 2003). Oxford, Update Software, 2003.
16.
Cook DJ, Guyatt GH, Laupacis A, Sacket DL, Goldberg RJ: Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995;108:227S-230S.
17.
Seshia SS, Young GB: The evidence-based medicine paradigm: where are we 20 years later? Part 2. Can J Neurol Sci 2013;40:475-481.
18.
Seshia SS, Young GB: The evidence-based medicine paradigm: where are we 20 years later? Part 1. Can J Neurol Sci 2013;40:465-474.
19.
Fava GA: Rational use of antidepressant drugs. Psychother Psychosom 2014;83:197-204.
20.
Gabbard G, Gunderson JG, Fonagy P: The place of psychoanalytic treatments within psychiatry. Arch Gen Psychiatry 2002;59:505-510.
21.
Luborsky L: Principles of Psychoanalytic Psychotherapy. Manual for Supportive-Expressive Treatment. New York, Basic Books, 1984.
22.
Wallerstein R: The psychotherapy research project of the Menninger foundation: an overview. J Consult Clin Psychol 1989;57:195-205.
23.
Gabbard GO: Long-term psychodynamic psychotherapy. Washington, American Psychiatric Publishing, 2004.
24.
OPD Task Force: Operationalized Psychodynamic Diagnosis OPD-2. Manual for Diagnosis and Treatment Planning. Göttingen, Hogrefe & Huber, 2008.
25.
Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, Lawrence Erlbaum, 1988.
26.
Kazdin AE, Bass D: Power to detect differences between alternative treatments in comparative psychotherapy outcome research. J Consult Clin Psychol 1989;57:138-147.
27.
Hofmann SG, Wu JQ, Boettcher H: Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: a meta-analysis. J Consult Clin Psychol 2014;82:375-391.
28.
Walker E, Nowacki AS: Understanding equivalence and noninferiority testing. J Gen Intern Med 2011;26:192-196.
29.
Barker LE, Luman ET, McCauley MM, Chu SY: Assessing equivalence: an alternative to the use of difference tests for measuring disparities in vaccination coverage. Am J Epidemiol 2002;156:1056-1061.
30.
Rogers JL, Howard KI, Vessey JT: Using significance tests to evaluate equivalence between two experimental groups. Psychol Bull 1993;113:553-565.
31.
Lesaffre E: Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis 2008;66:150-154.
32.
Kraemer HC, Kupfer DJ: Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006;59:990-996.
33.
Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG: Reporting of noninferiority and equivalence randomized trials: extension of the consort 2010 statement. JAMA 2012;308:2594-2604.
34.
Malan DH: The Frontier of Brief Psychotherapy. New York, Plenum, 1976.
35.
Sifneos PE: Short-term anxiety-provoking psychotherapy; in Davanloo H (ed): Short-Term Dynamic Psychotherapy. New York, Spectrum, 1978, pp 35-42.
36.
Davanloo H: Short-term Dynamic Psychotherapy. New York, Jason Aronson, 1980.
37.
Mann J: Time-Limited Psychotherapy. Cambridge, Harvard University Press, 1973.
38.
Strupp HH, Binder JL: Psychotherapy in a New Key: A Guide to Time-Limited Dynamic Psychotherapy. New York, Basic Books, 1984.
39.
Horowitz M, Kaltreider N: Brief therapy of the stress response syndrome. Psychiatr Clin North Am 1979;2:365-377.
40.
Burnand Y, Andreoli A, Kolatte E, Venturini A, Rosset N: Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiatr Serv 2002;53:585-590.
41.
de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J: Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord 2001;64:217-229.
42.
Thompson LW, Gallagher D, Breckenridge JS: Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol 1987;55:385-390.
43.
Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, Singer M, Turchin W, Klass ET, Graf E, Teres JJ, Shear MK: A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 2007;164:265-272.
44.
Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF: Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry 2007;164:922-928.
45.
Woody GE, Luborsky L, McLellan AT, O'Brien CP, Beck AT, Blaine A, Herman I, Hole A: Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry 1983;40:639-645.
46.
Woody GE, Luborsky L, McLellan AT, O'Brien CP: Psychotherapy in community methadone programs: a validation study. Am J Psychiatry 1995;152:1302-1308.
47.
Wiborg IM, Dahl AA: Does brief dynamic psychotherapy reduce the relapse rate of panic disorder? Arch Gen Psychiatry 1996;53:689-694.
48.
Winston A, Laikin M, Pollack J, Samstag LW, McCullough L, Muran JC: Short-term psychotherapy of personality disorders. Am J Psychiatry 1994;151:190-194.
49.
de Jonghe F, Hendricksen M, van Aalst G, Kool S, Peen V, Van R, van den Eijnden E, Dekker J: Psychotherapy alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry 2004;185:37-45.
50.
Driessen E, Van HL, Don FJ, Peen J, Kool S, Westra D, Hendriksen M, Schoevers RA, Cuijpers P, Twisk J, Dekker JJ: The efficacy of cognitive-behavioural therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry 2013;170:1041-1050.
51.
Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz LR, Thase ME, Weiss RD, Gastfriend DR, Woody GE, Barber JP, Butler SF, Daley D, Salloum I, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT: Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999;56:493-502.
52.
Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, Huesing J, Leibing E: Psychodynamic therapy and cognitive therapy in social anxiety disorder - a multi-center randomized controlled trial. Am J Psychiatry 2013;170:759-767.
53.
Knekt P, Lindfors O, Harkanen T, Valikoski M, Virtala E, Laaksonen MA, Marttunen M, Kaipainen M, Renlund C: Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up. Psychol Med 2008;38:689-703.
54.
Bögels SM, Wijts P, Oort FJ, Sallaerts SJ: Psychodynamic psychotherapy versus cognitive behavior therapy for social anxiety disorder: an efficacy and partial effectiveness trial. Depress Anxiety 2014;31:363-373.
55.
Zipfel S, Wild B, Gross G, Friederich H-C, Teufel M, Schellberg D, Herzog W: Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial. Lancet 2013;383:127-137.
56.
Vinnars B, Barber JP, Noren K, Gallop R, Weinryb RM: Manualized supportive-expressive psychotherapy versus nonmanualized community-delivered psychodynamic therapy for patients with personality disorders: bridging efficacy and effectiveness. Am J Psychiatry 2005;162:1933-1940.
57.
Hobson R: Forms of Feeling. The Heart of Psychotherapy. London, Tavistock, 1985.
58.
Shapiro DA, Firth JA: Exploratory Therapy Manual for the Sheffield Psychotherapy Project (SAPU Memo 733). Sheffield, University of Sheffield, 1985.
59.
Cooper PJ, Murray L, Wilson A, Romaniuk H: Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression. I. Impact on maternal mood. Br J Psychiatry 2003;182:412-419.
60.
Johannson R, Björklund M, Hornborg C, Karlsson S, Hesser H, Ljotsson B, Rousseau A, Frederick JJ, Andersson G: Affect-focused psychodynamic psychotherapy for depression and anxiety through the internet: a randomized controlled trial. PeerJ 2013;102:1-22.
61.
Johansson R, Ekbladh S, Hebert A: Psychodynamic guided self-help for adult depression through the internet: a randomised controlled trial. PLoS One 2012;7:e38021.
62.
Maina G, Forner F, Bogetto F: Randomized controlled trial comparing brief dynamic and supportive therapy with waiting list condition in minor depressive disorders. Psychother Psychosom 2005;74:3-50.
63.
Maina G, Rosso G, Crespi C, Bogetto F: Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study. Psychother Psychosom 2007;76:298-305.
64.
Beutel ME, Weissflog G, Leuteritz K, Wiltink J, Haselbacher A, Ruckes C, Kuhnt S, Barthel Y, Imruck BH, Zwerenz R, Brahler E: Efficacy of short-term psychodynamic psychotherapy (STPP) with depressed breast cancer patients: results of a randomized controlled multicenter trial. Ann Oncol 2014;25:378-384.
65.
Thase ME: Comparative effectiveness of psychodynamic psychotherapy and cognitive-behavioral therapy: It's about time, and what's next? Am J Psychiatry 2013;170:953-955.
66.
Salminen JK, Karlsson H, Hietala J, J K, Aalto S, Markkula J, Rasi-Hakala H, Toikka T: Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008;77:351-357.
67.
Shapiro DA, Barkham M, Rees A, Hardy GE, Reynolds S, Startup M: Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy. J Consult Clin Psychol 1994;62:522-534.
68.
Barber J, Barrett M, Gallop R, Rynn M, Rickels K: Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2012;73:66-73.
69.
McCallum M, Piper WE: A controlled study of effectiveness and patient suitability for short-term group psychotherapy. Int J Group Psychother 1990;40:431-452.
70.
Piper WE, McCallum M, Joyce AS, Ogrodniczuk J: Patient personality and time-limited group psychotherapy for complicated grief. Int J Group Psychother 2001;51:525-552.
71.
Knijnik DZ, Kapczinski F, Chachamovich E, Margis R, Eizirik CL: Psychodynamic group treatment for generalized social phobia. Rev Bras Psiquiatr 2004;26:77-781.
72.
Leichsenring F, Hoyer J, Beutel M, Herpertz S, Hiller W, Irle E, Joraschky P, König HH, de Liz TM, Nolting B, Pöhlmann K, Salzer S, Schauenburg H, Stangier U, Strauss B, Subic-Wrana C, Vormfelde S, Weniger G, Willutzki U, Wiltink J, Leibing E: The social phobia psychotherapy research network. The first multicenter randomized controlled trial of psychotherapy for social phobia: rationale, methods and patient characteristics. Psychother Psychosom 2009;78:35-41.
73.
Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, Huesing J, Joraschky P, Nolting B, Poehlmann K, Ritter V, Stangier U, Strauss B, Tefikow S, Teismann T, Willutzki U, Wiltink J, Leibing E: Long-term outcome of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder. Am J Psychiatry 2014;171:1074-1082.
74.
Knijnik DZ, Blanco C, Salum GA, Moraes CU, Mombach C, Almeida E, Pereira M, Strapasson A, Manfro GG, Eizirik CL: A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder. Eur Psychiatry 2008;23:567-574.
75.
Knijnik DZ, Salum GAJ, Blanco C, Moraes C, Hauck S, Mombach CK, Strapasson AC, Manfro GG, Eizirik CL: Defense style changes with the addition of psychodynamic group therapy to clonazepam in social anxiety disorder. J Nerv Ment Dis 2009;197:547-551.
76.
Beutel ME, Scheurich V, Knebel A, Michal M, Wiltink J, Graf-Morgenstern M, Tschan R, Milrod B, Wellek S, Subic-Wrana C: Implementing panic-focused psychodynamic psychotherapy into clinical practice. Can J Psychiatry 2013;58:326-334.
77.
Andersson G, Paxling B, Roch-Norlund P, Östman G, Norgren A, Almlöv J, Georén L, Breitholtz E, Dahlin M, Cuijpers P, Carlbring P, Silverberg F: Internet-based psychodynamic versus cognitive behavioral guided self-help for generalized anxiety disorder: a randomized controlled trial. Psychother Psychosom 2012;81:344-355.
78.
Leichsenring F, Salzer S, Jager U, Kächele U, Kreische R, Leweke F, Rüger U, Winkelbach C, Leibing E: Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized controlled trial. Am J Psychiatry 2009;166:875-881.
79.
Bressi C, Porcellana M, Marinaccio PM, Nocito EP, Magri L: Short-term psychodynamic psychotherapy versus treatment as usual for depressive and anxiety disorders: a randomized clinical trial of efficacy. J Nerv Ment Dis 2010;198:647-652.
80.
Brom D, Kleber RJ, Defares PB: Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol 1989;57:607-612.
81.
Maina G, Rosso G, Rigardetto S, Chiado Piat S, Bogetto F: No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression. Psychother Psychosom 2010;79:295-302.
82.
Monsen K, Monsen TJ: Chronic pain and psychodynamic body therapy. Psychotherapy 2000;37:257-269.
83.
Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J, Noll-Hussong M, Ohmann C, Ronel J, Sack M, Sauer N, Schneider G, Henningsen P: Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 2012;200:60-67.
84.
Bachar E, Latzer Y, Kreitler S, Berry EM: Empirical comparison of two psychological therapies. Self-psychology and cognitive orientation in the treatment of anorexia and bulimia. J Psychother Pract Res 1999;8:115-128.
85.
Poulsen S, Lunn S, Daniel SI, Folke S, Mathiesen BB, Katznelson H, Fairburn CG: A randomized controlled trial of psychoanalytic psychotherapy or cognitive-behavioral therapy for bulimia nervosa. Am J Psychiatry 2014;171:109-116.
86.
Tasca G, Hilsenroth M, Thompson-Brenner H: Psychoanalytic psychotherapy or cognitive-behavioral therapy for bulimia nervosa. Am J Psychiatry 2014;17:583-584.
87.
Poulsen S, Lunn S: Response to Tasca et al. Am J Psychiatry 2014;171:584.
88.
Garner DM, Rockert W, Davis R, Garner MV, Olmsted MP, Eagle M: Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa. Am J Psychiatry 1993;150:37-46.
89.
Fairburn CG, Kirk J, O'Connor M, Cooper PJ: A comparison of two psychological treatments for bulimia nervosa. Behav Res Ther 1986;24:629-643.
90.
Gowers D, Norton K, Halek C, Vrisp AH: Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. Int J Eat Disord 1994;15:165-177.
91.
Dare C, Eisler I, Russel G, Treasure J, Dodge L: Psychological therapies for adults with anorexia nervosa: randomised controlled trial of out-patient treatments. Br J Psychiatry 2001;178:216-221.
92.
Tasca GA, Ritchie K, Conrad G, Balfour L, Gayrton J, Lybanon V, Bissada H: Attachment scales predict outcome in a randomized clinical trial of group psychotherapy for binge eating disorder: an aptitude by treatment interaction. Psychother Res 2006;16:106-121.
93.
Woody GE, Luborsky L, McLellan AT, O'Brien CP: Corrections and revised analyses for psychotherapy in methadone maintenance patients. Arch Gen Psychiatry 1990;47:788-789.
94.
Sandahl C, Herlitz K, Ahlin G, Rönnberg S: Time-limited group psychotherapy for moderately alcohol dependent patients: a randomized controlled clinical trial. Psychother Res 1998;8:361-378.
95.
Levy KN, Meehan KB, Kelly KM, Reynoso JS, Weber M, Clarkin JF, Kernberg OF: Change in attachment patterns and reflective function in a randomized control trial of transference-focused psychotherapy for borderline personality disorder. J Consult Clin Psychol 2006;74:1027-1040.
96.
Doering S, Horz S, Rentrop M, Fischer-Kern M, Schuster P, Benecke C, Buchheim A, Martius P, Buchheim P: Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. Br J Psychiatry 2010;196:389-395.
97.
Gregory RJ, Chlebowski S, Kang D, Remen AL, Soderberg MG, Stepkovitch J, Virk S: A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. Psychotherapy 2008;45:28-41.
98.
Bateman A, Fonagy P: Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 2009;166:1355-1364.
99.
Clarkin J, Kernberg OF, Yeomans F: Transference-Focused Psychotherapy for Borderline Personality Disorder Patients. New York, Guilford, 1999.
100.
Munroe-Blum H, Marziali E: A controlled trial of short-term group treatment for borderline personality disorder. J Personal Disord 1995;9:190-198.
101.
Giesen-Bloo J, van Dyck R, Spinhoven P, van Tilburg W, Dirksen C, van Asselt T, Kremers I, Nadort M, Arntz A: Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2006;63:649-658.
102.
Yeomans F: Questions concerning the randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2007;64:610-611.
103.
Giesen-Bloo J, Arntz A: Questions concerning the randomized trial of schema-focused therapy vs transference-focused psychotherapy - reply. Arch Gen Psychiatry 2007;64:610-611.
104.
Svartberg M, Stiles T, Seltzer MH: Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders. Am J Psychiatry 2004;161:810-817.
105.
Muran JC, Safran JD, Samstag LW, Winston A: Evaluating an alliance-focused treatment for personality disorders. Psychotherapy 2005; 42:532-545.
106.
Emmelkamp P, Benner A, Kuipers A, Feiertag G, Koster HC, van Appelddorn FJ: Comparison of brief dynamic and cognitive-behavioral therapies in avoidant personality disorder. Br J Psychiatry 2006;189:60-64.
107.
Hellerstein DJ, Rosenthal RN, Pinsker H, Samstag LW, Muran JC, Winston A: A randomized prospective study comparing supportive and dynamic therapies. Outcome and alliance. J Psychother Pract Res 1998;7:261-271.
108.
Abbass AA, Sheldon A, Gyra J, Kalpin A: Intensive short-term psychotherapy for DSM-IV personality disorders: a randomized controlled trial. J Nerv Ment Dis 2008;196:211-216.
109.
Guthrie E, Kapur N, Mackway-Jones K, Chew-Graham C, Moorey J, Mendel E, Marino-Francis F, Sanderson S, Turpin C, Boddy G, Tomenson B: Randomised controlled trial of brief psychological intervention after deliberate self-poisoning. BMJ 2001;323:135-138.
110.
Guthrie E, Moorey J, Margison F, Barker H, Palmer S, McGrath G, Tomenson B, Creed F: Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services. Arch Gen Psychiatry 1999;56:519-526.
111.
Rosenbaum B, Harder S, Knudsen P, Koster A, Lajer M, Lindhardt A, Valbak K, Winther G: Supportive psychodynamic psychotherapy versus treatment as usual for first-episode psychosis: two-year outcome. Psychiatry 2012;75:331-341.
112.
Snyder DK, Wills RM: Behavioral vs. insight-oriented marital therapy: effects on individual and interspousal functioning. J Consult Clin Psychol 1989;57:39-46.
113.
Snyder DK, Wills RM, Grady-Fletcher A: Long-term effectiveness of behavioral versus insight-oriented marital therapy: a 4-year follow-up study. J Consult Clin Psychol 1991;59:138-141.
114.
Lazar SG, Yeomans FE: Guest editors' introduction. Psychodyn Psychiatry 2014;42:347-352.
115.
Parloff MB: Psychotherapy research evidence and reimbursement decisions: Bambi meets Godzilla. Am J Psychiatry 1982;139:718-727.
116.
Glass RM: Psychodynamic psychotherapy and research evidence: Bambi survives Godzilla? JAMA 2008;300:1587-1589.
117.
de Jonghe F: Psychoanalytic supportive psychotherapy. J Am Psychoanal Assoc 1994;42:421-446.
118.
Abbass AA, Kisely S, Kroenke K: Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and meta-analysis of clinical trials. Psychother Psychosom 2009:265-274.
119.
Richardson WS, Doster LM: Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability. J Clin Epidemiol 2014;67:244-246.
120.
Berk M, Parker G: The elephant on the couch: side effects of psychotherapy. Aust NZ J Psychiatry 2009;43:787-794.
121.
Greenson RR: The Techniques and Practice of Psychoanalysis. New York, International Universities Press, 1967.
122.
Abbass A, Sheldon A, Gyra J, Kalpin A: Intensive short-term dynamic psychotherapy for DSM-IV personality disorders: a randomized controlled trial. J Nerv Ment Dis 2008;196:211-216.
123.
Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF 3rd: The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013;12:137-148.
124.
Keefe JR, McCarthy KS, Dinger U, Zilcha-Mano S, Barber JP: A meta-analytic review of psychodynamic therapies for anxiety disorders. Clin Psychol Rev 2014;34:309-323.
125.
Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS: A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry 2013;58:376-385.
126.
Leichsenring F, Salzer S, Hilsenroth M, Leibing E, Leweke F, Rabung S: Treatment integrity: an unresolved issue in psychotherapy research. Curr Psychiatry Rev 2011;7:313-321.
127.
Baardseth TP, Goldberg SB, Pace BT, Wislocki AP, Frost ND, Siddiqui JR, Lindemann AM, Kivlighan DM 3rd, Laska KM, Del Re AC, Minami T, Wampold BE: Cognitive-behavioral therapy versus other therapies: redux. Clin Psychol Rev 2013;33:395-405.
128.
Gallagher-Thompson DE, Steffen AM: Comparative effects of cognitive-behavioral and brief psychodynamic psychotherapies for depressed family caregivers. J Consult Clin Psychol 1994;62:543-549.
129.
Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R: Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005;62:417-422.
130.
Shea MT, Elkin I, Imber SD, Sotsky SM, Watkins JT, Collins JF, Pilkonis PA, Beckham E, Glass DR, Dolan RT, et al: Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry 1992;49:782-787.
131.
Gallagher-Thompson DE, Hanley-Peterson P, Thompson LW: Maintenance of gains versus relapse following brief psychotherapy for depression. J Consult Clin Psychol 1990;58:371-374.
132.
Ablon JS, Jones EE: Validity of controlled clinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 2002;159:775-783.
133.
Ablon JS, Jones EE: How expert clinicians prototypes of an ideal treatment correlate with outcome in psychodynamic and cognitive-behavioral therapy. Psychother Res 1998;8:71-83.
134.
Ablon JS, Levy KN, Katzenstein T: Beyond brand names of psychotherapy: identifying empirically supported change processes. Psychotherapy (Chic) 2006;43:216-231.
135.
Luborsky L, Woody GE, McLellan AT, Rosenzweig J: Can independent judges recognize different psychotherapies? An experiment with manual-guided therapies. J Consult Clin Psychol 1982;30:49-62.
136.
Crits-Christoph P, Connolly Gibbons MB, Mukherjee D: Psychotherapy process-outcome research; in Lambert MJ (ed): Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. New York, Wiley, 2013.
137.
Barber JP, Crits-Christoph P, Luborsky L: Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. J Consult Clin Psychol 1996;64:619-622.
138.
Hilsenroth M, Ackerman SJ, Blagys MD, Baity MR, Mooney MA: Short-term psychodynamic psychotherapy for depression: an examination of statistical, clinically significant, and technique-specific change. J Nerv Ment Dis 2003;191:349-357.
139.
Slavin-Mulford J, Hilsenroth M, Weinberger J, Gold J: Therapeutic interventions related to outcome in psychodynamic psychotherapy for anxiety disorder patients. J Nerv Ment Dis 2011;199:214-221.
140.
Pitman S, Slavin-Mulford J, Hilsenroth M: Psychodynamic techniques related to outcome for anxiety disorder patients at different points in treatment. J Nerv Ment Dis 2014;202:391-396.
141.
Luborsky L, McLellan AT, Woody GE, O'Brien CP, Auerbach A: Therapy success and its determinants. Arch Gen Psychiatry 1985;42:602-611.
142.
Crits-Christoph P, Luborsky L: Changes in CCRT pervasiveness during psychotherapy; in Luborsky L, Crits-Christoph P (eds): Understanding Transference: The CCRT Method. New York, Basic Books, 1990, pp 133-146.
143.
Connolly Gibbons MB, Crits-Christoph P, Barber JP, Stirman SW, Gallop R, Goldstein LA, Temes CM, Ring-Kurtz S: Unique and common mechanisms of change across cognitive and dynamic psychotherapies. J Consult Clin Psychol 2009;77:801-813.
144.
Norton PJ, Phillip LM: Transdiagnostic approaches to the treatment of anxiety disorders: a quantitative review. Psychotherapy (Chic) 2008;45:214-226.
145.
Leichsenring F, Salzer S: A unified protocol for the transdiagnostic psychodynamic treatment of anxiety disorders: an evidence-based approach. Psychotherapy (Chic) 2014;51:224-245.
146.
Leichsenring F, Schauenburg H: Empirically supported methods of short-term psychodynamic therapy in depression - towards an evidence-based unified protocol. J Affect Disord 2014;169C:128-143.
147.
Busch FN, Singer MB, Milrod BL, Aronson AC: Manual of Panic-Focused Psychodynamic Psychotherapy - Extended Range. New York, Taylor & Francis, 2012.
148.
Thoma NC, McKay D, Gerber AJ, Milrod BL, Edwards AR, Kocsis JH: A quality-based review of randomized controlled trials of cognitive-behavioral therapy for depression: an assessment and metaregression. Am J Psychiatry 2012;169:22-30.
149.
Edwards SJ, Lilford RJ, Braunholtz D, Jackson J: Why ‘underpowered' trials are not necessarily unethical. Lancet 1997;350:804-807.
150.
Schulz KF, Grimes DA: Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005;365:1348-1353.
151.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR: Introduction to Meta-Analysis. Chichester, Wiley, 2011.
152.
Abbass A, Rabung S, Leichsenring F, Refseth J, Midgeley N: Psychodynamic psychotherapy for children and adolescents: a meta-analysis of short-term psychodynamic model. J Am Child Adolesc Psychiatry 2013;52:863-875.
153.
Kernberg OF: A psychoanalytic model for the classification of personality disorders; in Achenheil M, Bondy B, Engel R, Ermann M, Nedopil N (eds): Implications of Psychopharmacology to Psychiatry. New York, Springer, 1996.
154.
Cramer B, Robert-Tissot C, Stern D: Outcome evaluation in brief mother-infant psychotherapy: a preliminary report. Infant Ment Health J 1990;2:278-300.
155.
Stern D: The Motherhood Constellation. New York, Basic Books, 1995.
156.
de Jonghe F, de Maat S, Van R, Hendriksen M, Kool S, van Aalst G, Dekker J: Short-term psychoanalytic supportive psychotherapy for depressed patients. Psychoanal Inquiry 2013;33:614-625.
157.
Silverberg F: Make the Leap: A Practical Guide to Breaking the Patterns That Hold You Back. New York, Marlowe, 2005.
158.
Malan DH: A Study of Brief Psychotherapy. New York, Plenum, 1963.
159.
Haselbacher A, Barthel Y, Brähler E, Imruck B, Kuhnt S, Zwerenz R, Beutel ME: Psychodynamic short-term therapy for cancer patients suffering from depression. A treatment manual on the basis of Luborsky's supportive-expressive therapy (in German). Psychotherapeut 2010;55:321-328.
160.
Malan DH, Osimo F (eds): Psychodynamics, Training and Outcome in Brief Psychotherapy. Oxford, Butterworth-Heinemann, 1992.
161.
McCullough L, Kuhn N, Andrews S, Kaplan A, Wolf J, Hurley CL: Treating Affect Phobia. A manual for Short-Term Dynamic Psychotherapy. New York, Guilford Press, 2003.
162.
Frederick RJ: Living Like You Mean It: Use the Wisdom and Power of Your Emotions to Get the Life You Really Want. San Francisco, Jossey-Bass, 2009.
163.
McCallum M, Piper W: Psychoanalytically oriented short-term groups for outpatients; unsettled issues. Group 1988;12:21-32.
164.
McCallum M, Piper W, Joyce AS: Manual for time-limited, short-term, supportive group therapy for patients experiencing pathological bereavement. Unpubl Manuscript, 1995.
165.
Leichsenring F, Beutel ME, Leibing E: Psychodynamic psychotherapy for social phobia: a treatment manual based on supportive-expressive therapy. Bull Menninger Clin 2007;71:56-83.
166.
Milrod B, Busch F, Cooper A, Shapiro T: Manual of Panic-Focused Psychodynamic Psychotherapy. Washington, American Psychiatric Press, 1997.
167.
Monsen K, Monsen TJ: Affects and affect consciousness. A psychotherapy model of integrating Silvan Tomkins' affect and script theory within the framework of self-psychology; in Goldberg A (ed): Pluralism in Self-Psychology: Progress in Self-Psychology. Hillsdale, Analytic Press, 1999, vol 15, pp 287-306.
168.
Hardy G, Barkham M, Shapiro D, Guthrie E, Margison F: Psychodynamic-Interpersonal Psychotherapy. New York, Sage, 2011.
169.
PISO Working Group: Psychodynamic-Interpersonal Therapy for Somatoform Disorders (PISO) - A Manualized Short-Term Psychotherapy. Göttingen, Hogrefe, 2011.
170.
Bachar E: The contribution of self-psychology to the treatment of anorexia and bulimia. Am J Psychother 1998;52:147-165.
171.
Dare C: Psychoanalytic psychotherapy (of eating disorders); in Gabbard GO (ed): Treatment of Psychiatric Disorders. Washington, American Psychiatric Press, 1995, pp 2129-2151.
172.
Schauenburg H, Friederich HC, Wild B, Zipfel S, Herzog W: Focal psychodynamic psychotherapy of anorexia nervosa: a treatment manual. Psychotherapeut 2009;54:270-280.
173.
Bateman A, Fonagy P: Mentalization-based treatment of BPD. J Personal Disord 2004;18:36-51.
174.
Gregory RJ, Remen AL: A manual-based psychodynamic therapy for treatment-resistant borderline personality disorder. Psychotherapy (Chic) 2008;45:15-27.
175.
Guthrie E, Moorey J, Barker H, Margison F, McGrath G: Psychodynamic interpersonal psychotherapy in patients with treatment resistant psychiatric symptoms. Br J Psychother 1998;115:155-166.
176.
Nadelson CC, Paolino TJ: Marital therapy from a psychoanalytic perspective; in Paolino TJ, Crady BS (eds): Marriage and Marital Therapy: Psychoanalytic, Behavioral and Systems Theory Perspectives. New York, Brunner-Mazel, 1978, pp 89-164.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.